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Reactive lymphoid hyperplasia (RLH) of the liver is a rare and benign nodular lesion. It remains difficult to distinguish
RLH from hepatocellular carcinoma (HCC) despite recent advances in imaging modalities. We report five cases of RLH
that required differential diagnosis of HCC preoperatively. These cases all occurred in middle-aged women and
were associated with autoimmune disease in 40% (2/5). The diameter of the nodule was less than 2 cm in all five
of our cases. Four cases had a preoperative diagnosis of HCC. When a liver nodule is found in middle-aged
women with an autoimmune disease, the possibility of RLH should be considered.
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Reactive lymphoid hyperplasia (RLH) of the liver is a
rare and benign nodular lesion that is characterized on
histopathology by the proliferation of non-neoplastic
lymphocytes forming follicles [1]. To the best of our
knowledge, only 47 cases of hepatic RLH have been re-
ported in the English literature. Herein, we report five
cases of RLH of the liver and clarify the clinical features
of this lesion from a review of other cases.Case presentation
Patients’ characteristics
Five patients underwent hepatic resection for hepatocel-
lular carcinoma (HCC) at the Department of Gastro-
enterological Surgery and Transplantation Pediatric
Surgery Kumamoto University Hospital. All patients
were female with a median age of 55 years (range 44 to
68). Written informed consent was obtained from all the
patients before treatment. Median tumor size is 1.55 cm
(range 0.96 to 1.8). Two of the five patients (40%) had a
history of autoimmune disease which is primary biliary* Correspondence: hdobaba@kumamoto-u.ac.jp
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medium, provided the original work is properlycirrhosis (PBC). All cases were suggested malignant dis-
ease, and hepatic resection was performed (Table 1).
Preoperative findings
Computed tomography (CT) scan demonstrated hypo-
dense nodules that were immediately enhanced in the
early phase and quickly de-enhanced in the late phase
after injection of contrast (Table 2 and Figure 1).
Magnetic resonance imaging (MRI) showed a lower in-
tensity nodule on T1-weighted images and a higher inten-
sity nodule on T2-weighted images. Following injection of
contrast, MRI produced images that were similar to those
obtained with CT (Table 2 and Figure 2).
We calculated the apparent diffusion coefficient (ADC)
in four patients, but the mean ADC was 1.25 (range 1 to
1.6), and this was similar to the ADC reported for HCC.
Since both the CT and MRI images suggested hepatocel-
lular carcinoma or mucosa-associated lymphoid tissue
(MALT) lymphoma, distant metastasis was not observed
in all cases, and therefore, they underwent planned hep-
atic resection with their informed consent.
Histological findings
In all the cases, tumors were diagnosed as RLH based
on hematoxylin and eosin (HE) staining and immunohis-
tochemistry (Figure 3). HE staining showed a relativelyaccess article distributed under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited.
Table 2 Preoperative findings in five cases
Case CTA CTAP MRI T1-weighted images MRI T2-weighted images MRI arterial phase MRI venous phase ADC
1 Enhance De-enhance Hypo Hyper Enhance De-enhance 1.4
2 Enhance De-enhance Hypo Hyper ND ND 1
3 Enhance De-enhance Hypo Hyper ND ND ND
4 Enhance De-enhance Hypo Hyper Enhance De-enhance 1.6
5 Enhance De-enhance Hypo Hyper Enhance De-enhance 1.1
CTA, computed tomography angiography; CTAP, computed tomography during arterial portgraphy; MRI, magnetic resonance imaging; ADC, apparent diffusion
coefficient; ND, not determine.
Table 1 Characteristics of our five cases
Case Age Sex Child-Pugh (point) Size (cm) Preoperative diagnosis Background of the liver Therapy
1 60 F A (5) 0.96 HCC Normal Laparoscopic partial resection
2 68 F A (5) 1.4 MALT lymphoma Normal Segmentectomy
3 52 F B (8) 1.6 HCC PBC Transplantation
4 44 F A (5) 2 HCC Normal Segmentectomy
5 51 F A (5) 1.8 HCC PBC Partial resection
HCC, hepatocellular carcinoma; PBC, primary biliary cirrhosis.
Figure 1 CT demonstrated hypodense nodule. Immediately enhanced in the early phase (A) and quickly de-enhanced in the late phase (B)
after injection of contrast.
Figure 2 Contrast MRI showed a hyperintense nodule and hypointense nodule. A hyperintense nodule in the arterial phase (A) and a
hypointense nodule in the hepato-biliary phase (B).
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Figure 3 Histopathology revealed a relatively well-circumscribed nodular proliferation of mature-appearing small lymphocytes with
lymphoid follicles. The lymphoid follicles varied in size (A). The germinal centers were comprised of a mixture of small and large lymphoid cells
with no nuclear atypia. Strands of amorphous, hyalinized material were observed in the interfollicular areas (B).
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The germinal centers were comprised of a mixture of
small and large lymphoid cells. Strands of amorphous,
hyalinized material were observed in the interfollicular
areas.
Immunohistochemical studies (Figure 4) showed that
the follicles were mainly comprised of CD20-positive
lymphocytes, whereas CD3-positive cells were observedFigure 4 Immunohistochemical studies. The follicles were mainly compr
distributed between the follicles and around the circumference of the follicbetween the follicles and around the circumference of
the follicles. CD21-positive dendritic cells were distrib-
uted within the germinal center. The intrafollicular areas
contained CD138-positive plasma cells.
Discussion
Reactive lymphoid hyperplasia of the liver is an ex-
tremely rare condition, and only 47 cases of hepatic
RLH have been reported in the English literature. Inised of CD20-positive lymphocytes (A), while CD3-positive cells were
les (B). The stromal areas contained CD138-positive plasma cells (C).
Figure 5 Contrast MRI (A) and CT (B) showed perinodular enhancement in the equilibrium phase.
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(Table 1). RLH is a benign nodular lesion mainly de-
tected in the lung, stomach, small intestine, orbit, pan-
creas, skin, and breasts [2]. RLH occurs predominantly
in middle-aged women with a mean age of 55 years [3].
The male-female ratio of hepatic RLH reported in the
literature was 1:9.7 [3]. The diameter of the lesions
ranged from 0.4 to 5.5 cm; however, most were less than
2 cm [4]. In our five cases, RLH occurred in women,
and the diameter of the lesion was less than 2 cm. Al-
though the pathogenesis remains unknown, an associ-
ation between the development of hepatic RLH and
systemic or local immunological abnormalities has been
reported. Chronic liver diseases including HBV- or
HCV-related liver cirrhosis were found in 27% of pa-
tients, and autoimmune disorders such as PBC were di-
agnosed in 23% [5]. In our five cases, 40% (2/5) had an
autoimmune disorder (PBC). Chronic stimulation by
autoimmune antigens may play a role in RLH associated
with autoimmune disease [6].
Since RLH is a benign nodular lesion, preoperative
diagnosis of hepatic RLH by clinical imaging would be
useful to reduce unnecessary invasive procedures. How-
ever, preoperative differential diagnosis is extremely diffi-
cult because hepatic RLH has features similar to HCC
on various imaging modalities [1,7,8]. Several imaging
modalities in our cases showed that RLH could not be
distinguished from HCC (Table 1). Diffusion-weighted
MRI is sensitive to molecular diffusion and allows for
tissue characterization by probing tissue microstructural
changes. While the ADC [9] has been demonstrated to
be useful to distinguish malignant from benign lesions
[10], the mean ADC in our patients was 1.25 (range 1 to
1.6) and this was similar to the ADC reported for HCC.
However, making a diagnosis of RLH by using imaging
studies alone is challenging, there is an interesting report
to describe a unique finding in RLH [11]. It was shown
that the multiphasic contrast-enhanced CT and MRI
findings included a fact, which is ‘perinodular enhance-
ment,’ on arterial or equilibrium phase. In fact, to focuson the perinodular area in our cases, perinodular en-
hancement was observed on equilibrium phase (Fig-
ure 5). If we found a single and small (≦2 cm) tumor in
female patients who has no risk factors of HCC, the pos-
sibility of RLH should be considered. Additionally, the
careful observation of contrast-enhanced CT and MRI,
particularly the area of perinodular area, may lead to a
diagnosis of RLH.
Conclusions
We report five cases of hepatic RLH requiring differen-
tial diagnosis from HCC and MALT lymphoma. It is ex-
tremely difficult to diagnose RLH preoperatively because
it has features similar to HCC on various imaging mo-
dalities. When a liver nodule is found in middle-aged
women with an autoimmune disease, the possibility of
RLH should be considered.
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Written informed consent was obtained from the patient
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